Recommended insights
Are investor assumptions around NHS insourcing set to be challenged?
Health and Life Sciences
Structural and operational pressures – which have long been drivers for growth in the insourcing market – are here to stay, and any easing of these will occur from a high base. However, political scrutiny and pressure is growing and, in the context of the recent NHS Long Term Workforce Plan and a potential Labour government, this raises the risk of greater regulatory…
Global developments and the future of UK cancer screening
Health and Life Sciences
For patients given a timely cancer diagnosis, survival rates have never been better and, with revolutions in genomics and Artificial Intelligence (AI) gathering pace, the tide could soon turn comprehensively in favour of patients. However, the key to ensuring patients can benefit from this innovation is providing a comprehensive and accessible national screening service,…